These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 302530)

  • 1. Multiple myeloma, a 'B' cell blood dyscrasia.
    Anido V; Marcus G
    W V Med J; 1977 Sep; 73(9):221-5. PubMed ID: 302530
    [No Abstract]   [Full Text] [Related]  

  • 2. B lymphocyte markers in multiple myeloma and related plasma cell dyscrasias.
    Ricci C; Coscia G; Bozzone DM; Canavera RM; Baldassi R; Cascio G; Anania A; Marchi L; Verney MM
    Cancer Detect Prev; 1988; 11(3-6):423-32. PubMed ID: 3260538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin secretion by peripheral blood and bone marrow B cells in patients with multiple myeloma. Studies by the reverse haemolytic plaque assay.
    Dammacco F; Vacca A; Altomare E; Campobasso N
    Clin Exp Immunol; 1984 Sep; 57(3):743-51. PubMed ID: 6380841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukaemia with subsequent development of multiple myeloma. Evidence of two B-lymphocyte clones and of myeloma-induced suppression of secretion of an M-component and of normal immunoglobulins.
    Pedersen-Bjergaard J; Petersen HD; Thomsen M; Wiik A; Wolff-Jensen J
    Scand J Haematol; 1978 Sep; 21(3):256-64. PubMed ID: 309624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology of myeloma].
    Bataille R; Klein B; Rossi JF
    Nouv Rev Fr Hematol (1978); 1987; 29(4):255-64. PubMed ID: 3320951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of polyclonal B cell proliferation mediated by supernatants from human myeloma bone marrow cell cultures.
    Peest D; Hölscher R; Weber R; Leo R; Deicher H
    Clin Exp Immunol; 1989 Feb; 75(2):252-7. PubMed ID: 2784737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients.
    Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E
    Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Abnormality of the immunoregulatory system in multiple myeloma].
    Funato T
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1547-56. PubMed ID: 3879079
    [No Abstract]   [Full Text] [Related]  

  • 10. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 11. No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma.
    Duperray C; Bataille R; Boiron JM; Haagen IA; Cantaloube JF; Zhang XG; Boucheix C; Klein B
    Cancer Res; 1991 Jun; 51(12):3224-8. PubMed ID: 1904006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotype-bearing lymphoid cells in plasma cell neoplasia.
    Mellstedt H; Holm G; Pettersson D; Peest D
    Clin Haematol; 1982 Feb; 11(1):65-86. PubMed ID: 6978789
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional and biochemical characteristics of a soluble B lymphocyte proliferation-inhibiting activity produced by bone marrow cells from multiple myeloma patients.
    Quesada S; Leo R; Deicher H; Peest D
    Cell Immunol; 1995 May; 162(2):275-81. PubMed ID: 7743555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B and T cell markers of bone marrow and peripheral blood lymphoid cells in patients with paraproteinaemia.
    Husz S; Krizsa F; Dobozy A; Hunyadi J; Simon N
    Acta Haematol; 1977; 57(6):321-30. PubMed ID: 70148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies (MoAbs) for the ex vivo purging of the bone marrow in patients with multiple myeloma.
    Dinota A; Tazzari PL; Bontadini A; Grassi GP; Cerato C; Motta MR; Visani G; Cavo M; Gobbi M; Tura S
    J Exp Pathol; 1987; 3(4):363-7. PubMed ID: 3331648
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of antiserum against myeloma cells.
    Cawley LP; Goodwin WL; Minard BJ
    Cancer Res; 1973 Jan; 33(1):17-22. PubMed ID: 4629871
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of immunoglobulin synthesis using the hemolytic plaque technic in lymphoproliferative syndromes of B-cell lineage].
    González Echeverría FJ; Hernández Navarro F; Ancín Chandia MT; León Moya V; López Borrasca A
    Sangre (Barc); 1988 Aug; 33(4):269-76. PubMed ID: 3055364
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired synthesis of polyclonal immunoglobulin by bone marrow cells in a patient with multiple myeloma.
    Okubo H; Inoue T; Kudo J; Okumura Y; Hayashida K
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1083-9. PubMed ID: 4060978
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of intracytoplasmic immunoglobulins by cytofluorography].
    Filippi JF; Tubiana N; Le Caër F; Sampol J; Carcassonne Y
    Nouv Rev Fr Hematol (1978); 1986; 28(5):297-302. PubMed ID: 3492705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the peripheral blood lymphocytes stimulated by pokeweed mitogen in multiple myeloma patients].
    Evsev'eva AI; Abramenko IV
    Vrach Delo; 1987 Aug; (8):43-5. PubMed ID: 3500543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.